Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue

NCT01611259 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)

Interventions

DRUG: Rituximab and Lenalidomide

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie